Mallinckrodt (MNK +11.1%) perks up on modestly higher volume in apparent response to social media chatter that it is in merger talks with an unnamed company.
The company has been under a bankruptcy cloud due to its potential exposure to opioid crisis-related liabilities and a reimbursement cut to top seller Acthar Gel.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.